These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33941555)

  • 1. Effect of NTSR1 on the Proliferation and Invasion of Gastric Adenocarcinoma Cells, the Underlying Mechanism, and Clinical Role.
    Wang H; Huang D; Zhou Z
    Ann Clin Lab Sci; 2021 Mar; 51(2):163-173. PubMed ID: 33941555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
    Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
    Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
    Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
    Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.
    Akter H; Yoon JH; Yoo YS; Kang MJ
    Mol Cells; 2018 Jun; 41(6):591-602. PubMed ID: 29794962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma.
    Piper AK; Penney C; Holliday J; Tincknell G; Ma Y; Napaki S; Pantel K; Brungs D; Ranson M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J; Kou YB; Zhu JS; Chen WX; Li S
    Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
    Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
    Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
    Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
    World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604).
    Saeki H; Oki E; Kashiwada T; Arigami T; Makiyama A; Iwatsuki M; Narita Y; Satake H; Matsuda Y; Sonoda H; Shimokawa M; Maehara Y;
    Eur J Cancer; 2018 Dec; 105():41-49. PubMed ID: 30391779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
    Kim JT; Li J; Song J; Lee EY; Weiss HL; Townsend CM; Evers BM
    Oncotarget; 2015 Sep; 6(29):26960-70. PubMed ID: 26298774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.
    Ou-Yang Q; He X; Yang A; Li B; Xu M
    Cell Physiol Biochem; 2018; 49(6):2382-2395. PubMed ID: 30261490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
    Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
    World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.
    Gui X; Guzman G; Dobner PR; Kadkol SS
    Peptides; 2008 Sep; 29(9):1609-15. PubMed ID: 18541341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM98 mRNA promotes proliferation and invasion of gastric cells by directly interacting with NF90 protein.
    Ao X; Li X; Chen Y; Zang Z; Guo W; Liang J
    Cell Biol Int; 2020 Sep; 44(9):1820-1830. PubMed ID: 32379372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.
    Hashimoto K; Kyoda Y; Tanaka T; Maeda T; Kobayashi K; Uchida K; Kitamura H; Hirata K; Tsukamoto T; Masumori N
    Lab Invest; 2015 Mar; 95(3):283-95. PubMed ID: 25581609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
    Chen YJ; Wu H; Zhu JM; Li XD; Luo SW; Dong L; Liu TT; Shen XZ
    J Gastroenterol Hepatol; 2016 Jan; 31(1):155-63. PubMed ID: 26173586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.